Filtration of viral aerosols via a hybrid carbon nanotube active filter
Source abstract
Abstract
Exposure to expired particles and droplets carrying infectious viruses is a primary transmission pathway for respiratory diseases. Removal of particles and droplets via filtration from a volume can drastically reduce the exposure to viruses, but viruses may remain active on filtration surfaces as potential resuspension or fomite risks. Here, we report the development of macroscopic carbon nanotube air filters synthesized using ultra-thin carbon nanotube electrically conductive membranes, mechanically supported by a porous polyester backing. Filtration efficiencies were measured up to 99.999%, while ultra-thin materials with low areal density (0.1 g m─2) exhibited pressure drops comparable to commercial High-Efficiency Particulate Air (HEPA) filters. These electrically conductive filters are actively self-sanitized by thermal flashes via resistive heating to temperatures above 80 °C within seconds or less. Such temperatures were proven to achieve full deactivation of a betacoronavirus and an adeno-associated virus retained on filter surfaces. A filtration unit prototype equipped with a CNT filter module (∼1.2 m2) was shown to achieve air purification of 99% of a room within 10 min at 26 air changes per hour.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Infection Control and Ventilation · Innovative Energy Harvesting Technologies · Aerosol Filtration and Electrostatic Precipitation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?10.1177/0141076820956802 ↗
2. Economic Effects of Coronavirus Outbreak (COVID-19) on the World Economy
3. Baker
4. Airborne transmission of SARS-CoV-2: the world should face the reality10.1016/j.envint.2020.105730 ↗
5. Aerosol emission and superemission during human speech increase with voice loudness10.1038/s41598-019-38808-z ↗
6. Reducing transmission of SARS-CoV-2
7. The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission10.1073/pnas.2006874117 ↗
8. Recognition of aerosol transmission of infectious agents: a commentary10.1186/s12879-019-3707-y ↗
9. The flow physics of COVID-1910.1017/jfm.2020.330 ↗
10. Evolution of spray and aerosol from respiratory releases: theoretical estimates for insight on viral transmission
11. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-110.1056/NEJMc2004973 ↗
12. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals10.1038/s41586-020-2271-3 ↗
13. Mechanistic Transmission Modeling of COVID-19 on the Diamond Princess Cruise Ship Demonstrates the Importance of Aerosol Transmission
14. Coronavirus disease outbreak in call center, South Korea, emerg
15. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients10.1016/j.ijid.2020.09.025 ↗
16. Assessment and mitigation of aerosol airborne SARS-CoV-2 transmission in laboratory and office environments10.1080/15459624.2020.1805117 ↗
17. Air filtration in the free molecular flow regime: a review of high-efficiency particulate air filters based on Carbon Nanotubes10.1002/smll.201401553 ↗
18. High efficiency fine particulate filtration using carbon nanotube coatings10.1002/adma.200400463 ↗
19. Aerosol filtration enhancement using carbon nanostructures synthesized within a sintered nickel microfibrous matrix10.1016/j.seppur.2011.11.026 ↗
20. Performance improvement of micron-sized fibrous metal filters by direct growth of carbon nanotubes10.1016/j.carbon.2006.02.005 ↗
21. Filtration and inactivation of aerosolized bacteriophage MS2 by a CNT air filter fabricated using electro-aerodynamic deposition10.1016/j.carbon.2014.04.019 ↗
22. In situ fabrication of depth-type hierarchical CNT/quartz fiber filters for high efficiency filtration of sub-micron aerosols and high water repellency10.1039/c3nr34325a ↗
23. Hierarchical carbon-nanotube/quartz-fiber films with gradient nanostructures for high efficiency and long service life air filters10.1039/C4RA08746A ↗
24. Multifunctional free-standing single-walled carbon nanotube films10.1021/nn200338r ↗
25. Aligned carbon nanotube sheet high efficiency particulate air filters10.1016/j.carbon.2013.07.066 ↗
26. Plasmonic and superhydrophobic self-decontaminating N95 respirators10.1021/acsnano.0c03504 ↗
27. Reusable and recyclable graphene masks with outstanding superhydrophobic and photothermal performances10.1021/acsnano.0c02250 ↗
28. Flexible nanoporous template for the design and development of reusable anti-COVID-19 hydrophobic face masks10.1021/acsnano.0c03976 ↗
29. Reusable filters augmented with heating microfibers for antibacterial and antiviral sterilization
30. High-performance particulate matter including nanoscale particle removal by a self-powered air filter
31. Photoactive antiviral face mask with self-sterilization and reusability10.1021/acs.nanolett.0c03725 ↗
32. Stability of SARS-CoV-2 on critical personal protective equipment10.1038/s41598-020-80098-3 ↗
33. Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review
34. Direct spinning of carbon nanotube fibers from chemical vapor deposition synthesis10.1126/science.1094982 ↗
35. High-performance carbon nanotube fiber
36. Microbial cytotoxicity of carbon-based nanomaterials: implications for river water and wastewater effluent10.1021/es8031506 ↗
37. Characterization of biological aerosol exposure risks from automobile air conditioning system
38. Efficacy of antimicrobial filter treatments on microbial colonization of air panel filters10.1046/j.1365-2672.2003.01820.x ↗
39. Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system10.1016/j.mtphys.2020.100249 ↗
40. Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo10.1128/JVI.79.5.3097-3106.2005 ↗
41. A simple method of estimating fifty per cent endpoints10.1093/oxfordjournals.aje.a118408 ↗
42. Flow through interstitium and other fibrous matrices10.1113/expphysiol.1987.sp003085 ↗
43. Characterization of a support-free carbon nanotube-microporous membrane for water and wastewater filtration10.1016/j.seppur.2018.03.038 ↗
44. Electrotreated carbon nanotube membranes for facile oil-water separations10.1021/acsanm.8b00442 ↗
45. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model10.1073/pnas.240335297 ↗
46. Sars-cov-2 (Covid-19) by the numbers10.7554/eLife.57309 ↗
47. The size and concentration of droplets generated by coughing in human subjects
48. Hinds · 1999
49. Filtration of aerosols by fibrous media10.1021/cr50003a004 ↗
50. Thermal denaturation of influenza virus and its relationship to membrane fusion10.1042/bj20020290 ↗
51. Stability of SARS-CoV-2 in different environmental conditions
52. Thermal stability of hepatitis E virus10.1086/432488 ↗
53. Thermal stability as a determinant of AAV serotype identity10.1016/j.omtm.2017.07.003 ↗
54. High-fidelity characterization on anisotropic thermal conductivity of carbon nanotube sheets and on their effects of thermal enhancement of nanocomposites Related content10.1088/1361-6528/aacd7b ↗
55. Specific heat of aligned multiwalled carbon nanotubes10.1088/0957-4484/16/9/013 ↗
56. Electrochemical carbon-nanotube filter performance toward virus removal and inactivation in the presence of natural organic matter10.1021/es203607d ↗
57. The evaporation of sessile or pendant drops in still air10.1016/0021-9797(77)90396-4 ↗
58. On the lifetimes of evaporating droplets10.1017/jfm.2014.94 ↗
59. Volume evolution of small sessile droplets evaporating in stick-slip mode10.1103/PhysRevE.93.042805 ↗
60. Updated COVID-19 infection prevention and control guidance10.1038/s41415-020-2140-3 ↗
61. The annual impact of seasonal influenza in the US: measuring disease burden and costs10.1016/j.vaccine.2007.03.046 ↗